Back to
ALPS Advisors Inc.
TNGX
3 quarters
Position history for
ALPS Advisors Inc.'s holdings in Tango Therapeutics, Inc.
No. ALPS Advisors exited its TNGX (Tango Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 48,071 shares worth $174,000. ALPS Advisors first reported TNGX in Q2 2022 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$236,000
Total Shares Change
-52,145
Quarter-by-Quarter History
Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.